Polymer will lead microfluidics sales through 2036 with a 46.2% share, driven by cost-effective fabrication, compatibility with rapid prototyping methods, and suitability for disposable diagnostic chip production. Point of care testing leads with a 37.0% share. The market is set to reach USD 26.4 billion by 2026-end and USD 52.4 billion by 2036.